) The metropolitan Detroit area is home to a population that is ethnically and culturally diverse, and the Population Studies and Prevention Program brings together faculty with a variety of scholarly interests whose research is based on this diversity. The Program is composed of two interactive groups: 1) Population Studies, with a research emphasis on population-based studies of cancer etiology; and 2) Prevention, with a research emphasis on studies designed to prevent and/or control the development of cancer within this population. Our population-based studies focus on the interface between genetic and environmental exposures and their roles in the subsequent development of cancer. Although several different cancers are under investigation, our primary interests are in the etiology of breast, prostate, and lung cancers. Our prevention studies emphasize the roles that nutrition and tobacco prevention/cessation play in the prevention of cancer. Our primary interests involve the preventive effects of soy isoflavones, lycopene, folic acid, zinc, increased fruits and vegetables, and a low fat diet in a variety of cancers. The effects of these interventions on oxidative DNA damage, lipid peroxidation, serum sex-hormone levels, tissue markers of cell growth and differentiation, signal transduction, and growth factors are currently under investigation. We have 27 primary members and 10 clinical members within the Program. Currently, 18 of these members serve as Principal Investigators on 35 peer-reviewed research projects that are supported at the national level. Although faculty within the Program collaborate with faculty from all the other programs of our CCC, we have especially strong inter-Programmatic collaborations with investigators in the Breast Cancer, Prostate Cancer, and Molecular Biology and Genetics Programs. Approximately 80% of the research within this Program is supported by the CCC Core facilities and the research efforts of Program investigators are considerably enhanced by these Core facilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-22
Application #
6457246
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-04-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Mills, Anne M; Peres, Lauren C; Meiss, Alice et al. (2018) Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol :
Vaishampayan, Ulka N; Podgorski, Izabela; Heilbrun, Lance K et al. (2018) Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res :
Sexton, Rachel E; Hachem, Ali H; Assi, Ali A et al. (2018) Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8:16008
Campbell, Douglas H; Lund, Maria E; Nocon, Aline L et al. (2018) Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. PLoS One 13:e0196017

Showing the most recent 10 out of 826 publications